Amy Esler is associate professor of pediatrics at the University of Minnesota in Minneapolis.
Amy Esler
Assistant Professor of Pediatrics
University of Minnesota
From this contributor
Why we need a mouse version of a diagnostic test for autism
Researchers have developed behavioral measures that can accurately diagnose autism in people; these lessons can and should be applied to mice.
Why we need a mouse version of a diagnostic test for autism
By
Amy Esler, Nicola Grissom
21 March 2018 | 6 min read
Adjusting diagnostic tests for the DSM-5
As clinicians adopt the new criteria for autism, the many tests now used to diagnose the disorder may need to be modified, says Amy Esler.
Explore more from The Transmitter
Exclusive: Brain and spinal cord institute halts research, citing funding problems
The Burke Neurological Institute, which calls itself “the only research institute in the U.S. dedicated to finding treatments to repair the brain and spinal cord,” ceased research operations on 22 May.
Exclusive: Brain and spinal cord institute halts research, citing funding problems
The Burke Neurological Institute, which calls itself “the only research institute in the U.S. dedicated to finding treatments to repair the brain and spinal cord,” ceased research operations on 22 May.
By
Lauren Schenkman
4 June 2026 | 5 min read
When autistic kids grow up, Chapter 1: Those people
What leads an autism researcher to publish an intentionally inflammatory paper accusing the NIH of discrimination?
When autistic kids grow up, Chapter 1: Those people
What leads an autism researcher to publish an intentionally inflammatory paper accusing the NIH of discrimination?
By
Brady Huggett
4 June 2026 | 24 min listen
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
By
Natalia Mesa
3 June 2026 | 11 min read